Company page

Ryvu Therapeutics Sa

Ryvu Therapeutics SA is a public company listed on the Polish market under the ticker RVU. The company has a market capitalization of approximately 104.86 million USD. Ryvu is focused on developing innovative therapies for cancer treatment.

profileRVUAI content: aiUpdated May 29, 2026/company/ryvu-therapeutics-sa
Ryvu Therapeutics Sa logo
Ticker
RVU
Market cap
$104.9M
Sector
Health Technology
Industry
Pharmaceuticals: Major